Società Amarillo Biosciences, Inc. Other OTC
Azioni
AMAR
US02301P2056
Biotecnologia
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Point-of-care Testing
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -96,53% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 0 | 100,0 % | -96,53% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15/04/21 |
Lawrence Lin
COO | Chief Operating Officer | 55 | 01/08/21 |
Shu Ying Pan
SAM | Sales & Marketing | - | - |
Chih-Heng Lu
PRN | Corporate Officer/Principal | 44 | 11/08/21 |
Junyong Lee
LAW | General Counsel | 54 | 01/08/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Yao Chung Chiang
BRD | Director/Board Member | 70 | 15/04/21 |
Pao Sheng Wei
BRD | Director/Board Member | 66 | 15/06/22 |
Chung Yi Tsai
BRD | Director/Board Member | 47 | 15/04/21 |
Chung Jung Tsai
BRD | Director/Board Member | 52 | 15/04/21 |
Ting Chuan Lee
BRD | Director/Board Member | 40 | 15/04/21 |
Wen Han Chang
BRD | Director/Board Member | 60 | 15/04/21 |
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 6 144 506 | 2 857 736 ( 46,51 %) | 0 | 46,51 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+9,58% | 115 Mrd | |
+12,41% | 106 Mrd | |
-2,59% | 21,96 Mrd | |
-12,38% | 21,87 Mrd | |
-5,29% | 19,21 Mrd | |
-3,35% | 18,08 Mrd | |
-38,57% | 17,71 Mrd | |
+7,51% | 14,32 Mrd | |
+35,67% | 12,42 Mrd |